Inhibition of pivotal cardiac transcription factors in doxorubicin-induced cardiomyopathy

被引：0
|
作者：
Poizat, C
Sartorelli, V
Chung, G
Dow, J
Kloner, RA
Kedes, LH
机构：
[1] Inst Med Genet, Los Angeles, CA USA
[2] Good Samaritan Hosp, Inst Heart, Los Angeles, CA USA
[3] Inst Med Genet, Los Angeles, CA USA
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1104
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [41] Adiponectin Protects Doxorubicin-induced Cardiomyopathy in Mice
    Konishi, Masanori
    Haraguchi, Go
    Ishihara, Takashi
    Ohigashi, Hirokazu
    Saito, Kiyomi
    Nakano, Yasuko
    Isobe, Mitsuaki
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 : S34 - S34
  • [42] A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
    Ma, Xiao
    Ding, Yonghe
    Wang, Yong
    Xu, Xiaolei
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (136):
  • [43] Contractile failure in chronic doxorubicin-induced cardiomyopathy
    Boucek, RJ
    Dodd, DA
    Atkinson, JB
    Oquist, N
    Olson, RD
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (10) : 2631 - 2640
  • [44] Myofilament changes in doxorubicin-induced dilated cardiomyopathy
    Falcao-Pires, I.
    Goncalves Rodrigues, P.
    Barros, C.
    Miranda-Silva, D.
    Hamdani, N.
    Linke, W.
    Leite-Moreira, A. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S61 - S62
  • [45] Review of tests for monitoring doxorubicin-induced cardiomyopathy
    Ganz, WI
    Sridhar, KS
    Ganz, SS
    Gonzalez, R
    Chakko, S
    Serafini, A
    ONCOLOGY, 1996, 53 (06) : 461 - 470
  • [46] Adiponectin Protects Doxorubicin-Induced Cardiomyopathy in Mice
    Konishi, Masanori
    Haraguchi, Go
    Ishihara, Takashi
    Ohigashi, Hirokazu
    Isobe, Mitsuaki
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (06) : S41 - S41
  • [47] Adiponectin Protects Doxorubicin-induced Cardiomyopathy in Mice
    Konishi, Masanori
    Haraguchi, Go
    Ohigashi, Hirokazu
    Ishihara, Takashi
    Isobe, Mitsuaki
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (07) : S167 - S167
  • [48] BPM 31510 decreases doxorubicin-induced cardiomyopathy
    Narain, N. R.
    Mccook, J. P.
    Hughes, K.
    Mauro, L. M.
    Vishnudas, V.
    Sarangarajan, R.
    Jimenez, J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 534 - 534
  • [49] PREVENTION OF DOXORUBICIN-INDUCED CARDIOMYOPATHY BY REDUCED GLUTATHIONE
    VILLANI, F
    GALIMBERTI, M
    ZUNINO, F
    MONTI, E
    ROZZA, A
    LANZA, E
    FAVALLI, L
    POGGI, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (05) : 365 - 369
  • [50] Phenomapping for classification of doxorubicin-induced cardiomyopathy in rats
    Pajovic, Vladislav
    Kovacshazi, Csenger
    Kosic, Marija
    Vasic, Marko
    Dukic, Ljiljana
    Brenner, Gabor B.
    Giricz, Zoltan
    Bajic, Dragana
    Ferdinandy, Peter
    Japundzic-Zigon, Nina
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 423
12345